Earnings Feed
Start Free
Home/Filings/4/0001179110-05-012089
4//SEC Filing

KUNG ROBERT T V 4

Accession 0001179110-05-012089

CIK 0000815094other
View on SEC.govCompany Profile

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 5:13 PM ET

Size

21.6 KB

Accession

0001179110-05-012089

Insider Transaction Report

Form 4
Period: 2005-06-08
ABIOMED INCABMD
KUNG ROBERT T V
SVP, Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2005-06-08$9.36/sh+20,000$187,200→ 20,000 total
    Exercise: $9.36From: 2006-06-08Exp: 2015-06-08→ Common Stock (20,000 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $6.81From: 2003-07-01Exp: 2008-07-01→ Common Stock (40,000 underlying)
    40,000

  • Common Stock, $.01 par value

    (indirect: By Trust)
    100,200

  • Stock Option (right to buy)

    Exercise: $6.25From: 2001-08-12Exp: 2006-08-12→ Common Stock (7,000 underlying)
    7,000

  • Stock Option (right to buy)

    Exercise: $5.75From: 2002-05-27Exp: 2007-05-27→ Common Stock (10,000 underlying)
    10,000

  • Common Stock, $.01 par value

    (indirect: By Trust)
    16,968

  • Stock Option (right to buy)

    Exercise: $6.69From: 2001-07-01Exp: 2009-07-01→ Common Stock (20,000 underlying)
    20,000

  • Common Stock, $.01 par value

    (indirect: By Trust)
    87,060

  • Stock Option (right to buy)

    Exercise: $6.75From: 2004-06-25Exp: 2012-06-25→ Common Stock (50,000 underlying)
    50,000

  • Stock Option (right to buy)

    Exercise: $5.11From: 2005-06-25Exp: 2013-06-25→ Common Stock (16,000 underlying)
    16,000
Footnotes (12)
  • [F1]Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1992 Combination Stock Option Plan.
  • [F10]These shares are held in trust for the benefit of the reporting person's spouse.
  • [F11]Thirty percent of this option will become exercisable on each of 6/25/05 and 6/25/06 and an addtional 40 percent will become exercisable on 6/25/07.
  • [F12]These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
  • [F2]Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1998 Equity Incentive Plan.
  • [F3]Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
  • [F4]Options were fully exercisable on the date shown.
  • [F5]Thirty percent of this option will become exercisable on each of 7/1/01 and 7/1/02 and an addtional 40 percent will become exercisable on 7/1/03
  • [F6]Thirty percent of this option will become exercisable on each of 6/28/02 and 6/28/03 and an addtional 40 percent will become exercisable on 6/28/04.
  • [F7]Thirty percent of this option will become exercisable on each of 6/22/03 and 6/22/04 and an addtional 40 percent will become exercisable on 6/22/05.
  • [F8]Thirty percent of this option will become exercisable on each of 6/25/04 and 6/25/05 and an addtional 40 percent will become exercisable on 6/25/06.
  • [F9]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purposes.

Documents

1 file

Issuer

ABIOMED INC

CIK 0000815094

→
Entity typeother

Related Parties

1
  • filerCIK 0001203037

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:13 PM ET
Size
21.6 KB
View on SEC.gov